This concise MedicalMinute presentation provides an expert overview of approved and guideline-recommended oral HIV PrEP regimens as well as key insights on determining PrEP candidacy and important considerations for specific populations/clinical scenarios, including adolescents, pregnancy/breastfeeding, and transgender individuals.
Consider expert perspectives on approved and guideline-recommended oral HIV PrEP regimens as well as key insights on determining PrEP candidacy and important considerations for specific populations/clinical scenarios, including adolescents, pregnancy/breastfeeding, and transgender individuals.
This concise MedicalMinute presentation provides an expert overview of investigational long-acting HIV PrEP regimens in late stages of clinical development.
Consider expert perspectives on investigational long-acting HIV PrEP regimens in late stages of clinical development.
See an expert overview of the different antiretroviral drug formulations and dosing strategies in various stages of clinical development for long-acting HIV PrEP—advances that collectively offer the potential for highly individualized approaches to HIV biomedical prevention.
Consider expert perspectives on the different antiretroviral drug formulations and dosing strategies in various stages of clinical development for long-acting HIV PrEP—advances that collectively offer the potential for highly individualized approaches to HIV biomedical prevention.
As a person who has chosen to take PrEP to protect myself from HIV infection, here are my thoughts on daily PrEP use, how it has kept me healthy, and what opportunities future PrEP options may offer.
In this podcast, CCO’s expert faculty discusses approved and guideline-recommended oral HIV PrEP regimens and provides key insights on determining PrEP candidacy and important considerations for specific populations or clinical scenarios, including adolescents, pregnancy/breastfeeding, and transgender individuals.
In this podcast, CCO’s expert faculty discusses key features and available safety and efficacy data on investigational long-acting HIV pre-exposure prophylaxis strategies that are in late stages of clinical development.
In this podcast, Nicholas Chamberlain, MD, provides an overview of the different antiretroviral drug formulations and dosing strategies in various stages of clinical development for long-acting HIV PrEP—advances that collectively offer the potential for highly individualized approaches to HIV biomedical prevention.
In this podcast, I share my thoughts as a person who has chosen to take PrEP to protect myself from HIV infection. Listen in on my experience with daily oral PrEP use, how it has kept me healthy, and what opportunities future PrEP options may offer.
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.